FUKOKU MUTUAL LIFE INSURANCE Co Raises Position in The Procter & Gamble Company (NYSE:PG)

FUKOKU MUTUAL LIFE INSURANCE Co raised its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 4.6% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 10,789 shares of the company’s stock after buying an additional 477 shares during the period. FUKOKU MUTUAL LIFE INSURANCE Co’s holdings in Procter & Gamble were worth $1,869,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in PG. Concurrent Investment Advisors LLC lifted its stake in Procter & Gamble by 4.5% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after acquiring an additional 4,035 shares during the period. Radnor Capital Management LLC acquired a new stake in shares of Procter & Gamble in the 3rd quarter worth $5,705,000. Welch Group LLC raised its position in shares of Procter & Gamble by 0.9% during the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after buying an additional 2,990 shares during the period. GAMMA Investing LLC lifted its stake in shares of Procter & Gamble by 67.2% in the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock valued at $4,420,000 after purchasing an additional 10,777 shares during the last quarter. Finally, Quintet Private Bank Europe S.A. boosted its stake in Procter & Gamble by 15.0% during the third quarter. Quintet Private Bank Europe S.A. now owns 426,820 shares of the company’s stock worth $73,925,000 after buying an additional 55,620 shares during the period. 65.77% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Procter & Gamble news, CEO Jon R. Moeller sold 31,797 shares of Procter & Gamble stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $5,380,688.34. Following the completion of the transaction, the chief executive officer now owns 300,777 shares in the company, valued at approximately $50,897,483.94. This trade represents a 9.56 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Andre Schulten sold 13,041 shares of Procter & Gamble stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the sale, the chief financial officer now owns 37,208 shares in the company, valued at approximately $6,325,360. This trade represents a 25.95 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 313,597 shares of company stock valued at $53,268,499 over the last ninety days. Company insiders own 0.18% of the company’s stock.

Analyst Upgrades and Downgrades

PG has been the subject of several research reports. Wolfe Research raised Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a research note on Monday, September 30th. Dbs Bank cut shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Morgan Stanley raised their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Finally, Jefferies Financial Group downgraded Procter & Gamble from a “buy” rating to a “hold” rating and dropped their price objective for the company from $182.00 to $175.00 in a report on Wednesday, July 24th. Nine analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus price target of $177.00.

View Our Latest Report on Procter & Gamble

Procter & Gamble Trading Up 0.3 %

PG opened at $167.08 on Friday. The company has a 50-day simple moving average of $170.61 and a 200 day simple moving average of $168.28. The stock has a market capitalization of $393.48 billion, a price-to-earnings ratio of 28.81, a P/E/G ratio of 3.60 and a beta of 0.42. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a twelve month low of $142.50 and a twelve month high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. Procter & Gamble’s revenue was down .6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.83 EPS. Analysts predict that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.41%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s payout ratio is currently 69.48%.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.